AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL
· Real-Time Price · USD
3.16
-0.04 (-1.25%)
At close: Jun 16, 2025, 3:59 PM
3.15
-0.35%
After-hours: Jun 16, 2025, 07:59 PM EDT
-1.25% (1D)
| Bid | 2.38 |
| Market Cap | 943.57M |
| Revenue (ttm) | 23.11M |
| Net Income (ttm) | -167.87M |
| EPS (ttm) | -0.56 |
| PE Ratio (ttm) | -5.64 |
| Forward PE | -5.65 |
| Analyst | Buy |
| Ask | 3.95 |
| Volume | 7,086,984 |
| Avg. Volume (20D) | 4,605,239 |
| Open | 3.30 |
| Previous Close | 3.20 |
| Day's Range | 3.05 - 3.36 |
| 52-Week Range | 1.89 - 3.68 |
| Beta | 0.36 |
About ABCL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ABCL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ABCL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+15.94%
Shares of healthcare technology stocks are trading...
Unlock content with
Pro Subscription
3 months ago
-11.3%
AbCellera Biologics shares are trading lower after the company reported worse-than-expected Q4 sales results. Also, Stifel cut its price target on the stock from $12 to $10.
